GPC1 and pancreatic neoplasm: These GPC1-positive crExos were specifically detected in the serum of individuals with pancreatic cancer, demonstrating high specificity and sensitivity for distinguishing healthy individuals, patients with benign pancreatic conditions, and those with PAnINs, early, and advanced stages of pancreatic cancer [86].